Physician profile
Alex Wu
NPI 1952989063
$1,340.01
in general payments reported to CMS, 2019-2025
24 companies · $723 in 2025
The $723 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.44 · 2022: $38.37 · 2023: $36.83 · 2024: $526 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.70 |
| Education | $232.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $212.26 | 2024-2025 | Calquence, Enhertu |
| Lilly USA, LLC | $191.93 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Merck Sharp & Dohme LLC | $105.26 | 2024-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $103.13 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.69 | 2024-2025 | Ninlaro, Fruzaqla |
| Seagen INC. | $74.99 | 2024 | |
| Novartis Pharmaceuticals Corporation | $67.92 | 2025 | |
| Daiichi Sankyo INC. | $67.68 | 2025 | Enhertu, Datroway |
| Glaxosmithkline, LLC. | $63.82 | 2025 | Jemperli, Zejula |
| Sobi, INC | $62.21 | 2024-2025 | Vonjo |
| Eisai INC. | $43.44 | 2025 | |
| Beone Medicines USA, INC. | $29.88 | 2025 | Tevimbra |
| Springworks Therapeutics, INC. | $25.16 | 2025 | Ogsiveo |
| Mirati Therapeutics, INC. | $24.00 | 2024 | Krazati |
| Exact Sciences Corporation | $22.03 | 2023 | Cologuard Collection Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.58 | 2022 | |
| Recordati_rare_diseases_inc. | $20.91 | 2024 | Sylvant |
| Abbvie INC. | $20.27 | 2025 | |
| Tempus Ai, INC | $20.14 | 2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $20.05 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.63 | 2025 | |
| Novo Nordisk INC | $16.79 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.44 | 2021 | |
| Inari Medical, INC. | $14.80 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.